In today’s podcast directed to physicians, PWN co-founder Dr. Lewis Blevins discusses the drug Recolev® (levoketoconazole) recently approved by the FDA to treat endogenous Cushing’s Syndrome.
In today’s podcast directed to physicians, PWN co-founder Dr. Lewis Blevins discusses the drug Recorlev® (levoketoconazole) recently approved by the FDA to treat endogenous Cushing’s Syndrome. While this podcast contains medical and technical terminology, we encourage patients to listen to it and discuss it with their physicians.
Music by REDproductions®[/vc_column_text][/vc_column][/vc_row]
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
